PHARMACOKINETICS OF FINGOLIMOD AND METABOLITES IN SUBJECTS WITH SEVERE RENAL IMPAIRMENT: AN OPEN-LABEL, SINGLE-DOSE, PARALLEL-GROUP STUDY Article David O.J., Pryce M., Meiser K., Picard F., Emotte C., Kobalava Z., Moiseev V., Schmouder R. International Journal of Clinical Pharmacology and Therapeutics. Dustri-Verlag Dr. Karl Feistle. Vol. 53. 2015. P. 547-854